These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7009450)

  • 21. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current thoughts on the immunology of leprosy].
    Sagaró Delgado B; Díaz de la Rocha Quevedo A; Díaz García MA; Martínez Granja R; Rodríguez García MA; Collazo Caballero S
    Rev Cubana Med Trop; 1988; 40(1):80-90. PubMed ID: 3045919
    [No Abstract]   [Full Text] [Related]  

  • 24. [Leprosy as an immunological model].
    Godal T; Myrvang B; Samuel DR
    Tidsskr Nor Laegeforen; 1973 Feb; 93(4):217-22. PubMed ID: 4570661
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigations related to the development of a leprosy vaccine.
    Convit J; Aranzazu N; Ulrich M; Zúñiga M; de Aragón ME; Alvarado J; Reyes O
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):531-9. PubMed ID: 6231259
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical applications of recent advances in immunology of leprosy.
    Talwar GP; Moudgil KD; Munshi A
    Indian J Lepr; 1987; 59(2):119-26. PubMed ID: 3309081
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of immunosuppression and immunodeficiency on infections with leprosy and tuberculosis.
    Strickland NH
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):86-100. PubMed ID: 2987376
    [No Abstract]   [Full Text] [Related]  

  • 28. The immunology of leprosy.
    Rook GA
    Tubercle; 1983 Dec; 64(4):297-312. PubMed ID: 6362155
    [No Abstract]   [Full Text] [Related]  

  • 29. HLA and susceptibility to leprosy.
    Serjeantson SW
    Immunol Rev; 1983; 70():89-112. PubMed ID: 6339369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy.
    Roche PW; Neupane KD; Britton WJ
    Clin Exp Immunol; 1992 Jul; 89(1):110-4. PubMed ID: 1628419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings].
    Rojas-Espinosa O; Jiménez-Zamudio L; Arce-Paredes P
    Rev Latinoam Microbiol; 1994; 36(3):213-9. PubMed ID: 7709098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination in leprosy--observations and interpretations.
    Convit J; Ulrich M; Aranzazu N
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):62-5. PubMed ID: 6988347
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunology of human leprosy--current status.
    Nath I
    Lepr Rev; 1983 Jun; Spec No():31-45. PubMed ID: 6224992
    [No Abstract]   [Full Text] [Related]  

  • 34. [The genetic susceptibility to leprosy in humans].
    Lagrange PH; Abel L
    Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothesis: do phases of immunosuppression during a Mycobacterium leprae infection determine the leprosy spectrum?
    Stoner GL
    Lepr Rev; 1981 Mar; 52(1):1-10. PubMed ID: 6454034
    [No Abstract]   [Full Text] [Related]  

  • 36. Natural history of leprosy--aspects relevant to a leprosy vaccine.
    Fine PE
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):553-5. PubMed ID: 6368419
    [No Abstract]   [Full Text] [Related]  

  • 37. Leprosy vaccine.
    Newmark P
    Microbiol Sci; 1984 Jun; 1(3):78-9. PubMed ID: 6242878
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoclonal antibodies and recombinant DNA technology: present and future uses in leprosy and tuberculosis.
    Seckl MJ
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):618-40. PubMed ID: 3910750
    [No Abstract]   [Full Text] [Related]  

  • 39. The rationale behind a leprosy vaccine research program.
    Godal T
    Int J Lepr Other Mycobact Dis; 1977; 45(1):61-3. PubMed ID: 326685
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunology of Leprosy: lessons from and for leprosy.
    Ottenhoff TH
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):108-21. PubMed ID: 8189076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.